ARCHIVES

Blood Vessel Growth Inhibitor May Be Tested Against KS

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

American Cancer Society Elects Officers, Distributes Awards

November 24, 1995

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989